PORT WASHINGTON, NY — Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, has launched Supra™ AKS depth filters for biotechnology and pharmaceutical purification applications. The new intermediate-size cartridges give process developers important new scale-up options when using Pall’s line of depth filters featuring Seitz® AKS immobilized activated carbon depth filter media.

“Pall’s Supra AKS depth filters allow users to purify and decolorize pharmaceutical products by activated carbon adsorption using a modular format,” said Scott W. Anderson, global product manager at Pall Life Sciences. “Filters can be quickly installed into standard sanitary-style cartridge housings, and the unique design reduces the risks of downstream contamination.

Pall leads the industry with nine optimized carbon-containing media grades and four scalable filter formats. The new Supra AKS cartridges fill a gap in sizes between the small 26 cm2 Supracap™ 60 capsules and the larger-scale Supradisc™ I modules. Mid-scale Supra AKS cartridges are ideal for confirming results seen at smaller scales, and they are appropriate for process scales from six to 100-plus liters.

The mid-range Supra AKS depth filters are available in standard 10-inch, 20-inch and 30-inch sanitary-style cartridge sizes. They feature a unique upstream-downstream separator and a Code 7 housing adapter for ease of use in stainless steel housings. The robust design withstands up to 80 °C at 35 psi (2.4 bar) differential pressure.

Pall’s Seitz AKS filter media incorporates activated carbon within a matrix of cellulosic fibers. The media is coupled with a downstream filter that eliminates carbon particle shedding. Unlike bulk powdered activated carbon (PAC) processing that entails multiple steps, the feed stream is passed through the Seitz AKS sheet filter just once at an appropriate flow rate to achieve the desired adsorptive purification. By streamlining the filtration process to a single step, Pall Seitz AKS filter media significantly reduces overall process time while increasing product yield.

Supra™ AKS depth filters are available through Pall Life Sciences and can be ordered by phone at 800-717-7255 in the U.S. or +41 (0)26 350 53 00 in Europe. For a complete listing of international offices, visit Pall online at www.pall.com/contact.

Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. Pall technologies are also used to collect and process blood components and help protect patients from hospital-acquired infections. The company’s membranes and membrane devices optimize detection and sample preparation in the drug research, clinical diagnostics, genomics, and proteomics markets. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce.

About Pall Corporation

Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing Total Fluid ManagementSM solutions to meet the critical needs of customers in biopharmaceutical; hospital, transfusion and veterinary medicine; energy and alternative energy; electronics; municipal and industrial water; aerospace; transportation and broad industrial markets. Together with our customers, we foster health, safety and environmentally responsible technologies. The Company’s engineered solutions enable process and product innovation and minimize emissions and waste. Pall Corporation, with total revenues of $2.3 billion for fiscal 2009, is an S&P 500 company with more than 10,000 employees servicing customers worldwide. Pall has been named a top “green company” by Newsweek magazine. To see how Pall is helping enable a greener and more sustainable future, visit www.pall.com.